Patent ID: 11896606
Assignee: HIGHLIGHT THERAPEUTICS, S.L.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 4:
5. The aqueous composition according to claim 1, wherein:
(i) between 5% and 60% of the double-stranded polyribonucleotides have less than 400 base pairs;
(ii) between 20% and 45% of the double-stranded polyribonucleotides have between 400 and 850 base pairs;
(iii) between 20% and 70% of the double-stranded polyribonucleotides have between 850 and 5000 base pairs; and/or
(iv) between 0% and 10% of the double-stranded polyribonucleotides have more than 5000 base pairs.